COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 in Wuhan city, Hubei province, China. This is the third and largest coronavirus outbreak since the new millennium after SARS in 2002 and Middle East respiratory syndrome (MERS) in 2012. Over 3 million people ha...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Ophthalmol
Autori principali: Thng, Zheng Xian, De Smet, Marc D, Lee, Cecilia S, Gupta, Vishali, Smith, Justine R, McCluskey, Peter J, Thorne, Jennifer E, Kempen, John H, Zierhut, Manfred, Nguyen, Quan Dong, Pavesio, Carlos, Agrawal, Rupesh
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316101/
https://ncbi.nlm.nih.gov/pubmed/32532764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316586
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi